4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution.

      Liver Transplantation
      Angiogenesis Inhibitors, therapeutic use, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Hemodynamics, Humans, Liver Diseases, drug therapy, Telangiectasia, Hereditary Hemorrhagic, Treatment Outcome, Vascular Malformations

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Comments

          Comment on this article